Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.31
+0.55 (7.09%)
At close: May 12, 2025, 4:00 PM
8.34
+0.03 (0.36%)
After-hours: May 12, 2025, 7:51 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $486.40 million as of May 12, 2025. Its market cap has decreased by -71.27% in one year.
Market Cap
486.40M
Enterprise Value
404.04M
1-Year Change
-71.27%
Ranking
Category
Stock Price
$8.31
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $486.40M, a decrease of -77.71%. That is a compound annual growth rate of -30.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 421.88M | -19.07% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |